In fact, it is evident that the synthetic process, which the molecular precursor (Eu ion) was be transformed fluorescent Eu complex in the cancerous cells, may depend on some special biochemical characteristics and peculiar microenvironment in cancer cells, involving in the significance of NADPH-oxidases and GSH as well as metabolic pathway. This evidence concerns the gene FMO5 and cancer.